{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:17Z","timestamp":1786119437037,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003122","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T14:33:10Z","timestamp":1462199590000},"page":"e3122","source":"Crossref","is-referenced-by-count":8,"title":["The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes"],"prefix":"10.1097","volume":"95","author":[{"given":"Roland E.","family":"Schmieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2014.09.016","article-title":"Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease","volume":"128","author":"Bohm","year":"2015","journal-title":"Am J Med"},{"key":"R2-14-20210309","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00125-012-2471-y","article-title":"Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus","volume":"55","author":"Hillis","year":"2012","journal-title":"Diabetologia"},{"key":"R3-14-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00392-013-0644-4","article-title":"Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET\/TRANSCEND","volume":"103","author":"Lonn","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"R4-14-20210309","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00392-013-0570-5","article-title":"Heart rate differentiates urgency and emergency in hypertensive crisis","volume":"102","author":"Al Bannay","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"R5-14-20210309","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"R6-14-20210309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0002-8703(91)90970-S","article-title":"Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study","volume":"121","author":"Gillum","year":"1991","journal-title":"Am Heart J"},{"key":"R7-14-20210309","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","article-title":"Influence of heart rate on mortality among persons with hypertension: the Framingham Study","volume":"125","author":"Gillman","year":"1993","journal-title":"Am Heart J"},{"key":"R8-14-20210309","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.109.144808","article-title":"Resting heart rate pattern during follow-up and mortality in hypertensive patients","volume":"55","author":"Paul","year":"2010","journal-title":"Hypertension"},{"key":"R9-14-20210309","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"R10-14-20210309","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"R11-14-20210309","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diab.41.6.736","article-title":"Prospective study of microalbuminuria as predictor of mortality in NIDDM","volume":"41","author":"Mattock","year":"1992","journal-title":"Diabetes"},{"key":"R12-14-20210309","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/diab.44.11.1303","article-title":"Albuminuria and poor glycemic control predict mortality in NIDDM","volume":"44","author":"Gall","year":"1995","journal-title":"Diabetes"},{"key":"R13-14-20210309","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"R14-14-20210309","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/HJH.0b013e3282f05c8a","article-title":"Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH","volume":"26","author":"Bohm","year":"2008","journal-title":"J Hypertens"},{"key":"R15-14-20210309","doi-asserted-by":"crossref","first-page":"e002832","DOI":"10.1161\/JAHA.112.002832","article-title":"Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus","volume":"1","author":"Hillis","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"R16-14-20210309","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"key":"R17-14-20210309","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"R18-14-20210309","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"R20-14-20210309","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.hjh.0000202820.56201.e6","article-title":"Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study","volume":"24","author":"Haller","year":"2006","journal-title":"J Hypertens"},{"key":"R21-14-20210309","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"R22-14-20210309","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/joim.12333","article-title":"Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies","volume":"278","author":"Bohm","year":"2015","journal-title":"J Intern Med"},{"key":"R23-14-20210309","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/eurheartj\/ehp124","article-title":"Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients","volume":"30","author":"Bohm","year":"2009","journal-title":"Eur Heart J"},{"key":"R24-14-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5551\/jat.6247","article-title":"Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial","volume":"18","author":"Pfister","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"R25-14-20210309","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1681\/ASN.2006060560","article-title":"Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial","volume":"17","author":"Ruggenenti","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R26-14-20210309","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"R27-14-20210309","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"R28-14-20210309","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000003122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:23Z","timestamp":1786039763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201604120-00014"}},"subtitle":["A Subanalysis of the ROADMAP Study"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003122","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}